Dental artificial intelligence company Overjet recently received FDA 501(k) clearance for its Periapical Radiolucency Assist device.
Overjet's device detects instances of periapical radiolucency on radiographs.
This is Overjet's fifth FDA clearance, according to a Nov. 9 news release. The clearance makes the company the first and only dental AI provider capable of detecting and outlining instances of periapical radiolucency on radiographs for patients ages 12 and older.